Brief: Phathom Pharmaceuticals Reports Q4 And Full Year 2022 Financial Results
28/02/2023 13:58
Feb 28 (Reuters) - Phathom Pharmaceuticals Inc PHAT.O :
* PHATHOM PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* PHATHOM PHARMACEUTICALS -BASED ON CURRENT OPERATING PLAN,
BELIEVES IT WILL HAVE SUFFICIENT CAPITAL TO FUND OPERATIONS
THROUGH 2024
* Q4 EARNINGS PER SHARE VIEW $-1.35 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXHHXJG
Further company coverage: PHAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates